Table 2 Characteristics of patient with cfDNA analysis on peritoneal washings
From: Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
cfDNA- on peritoneal washing | cfDNA + on peritoneal washing | |
|---|---|---|
Total (n = 4) | Total (N = 3) | |
Histology – n (%) | ||
Serous High Grade | 3 (75) | 3 (100) |
Endometrioid | 1 (25) | |
Type of ascites – n (%) | ||
Indirect | 4 (100) | 3 (100) |
Status at sample – n (%) | ||
Primary laparoscopy | 0 (0) | 1 (33,3) |
Secondary laparoscopy | 4 (100) | 2 (66,7) |
Neoadjuvant treatment – n (%) | ||
Carboplatine Taxol | 3 (75) | 2 (66,7) |
Carboplatine and Gemcitabine | 1 (25) | |
Number of cycle of chemotherapy – n (%) | ||
Median (IQR) | 3,5 (± 1,5) | 6 |
Response to chemotherapy – n (%) | ||
Biological response | 4 (100) | 2 (66,7) |
Radiographical response | 4 (100) | 2 (66,7) |
Histological response | 3 (75) | 0 (0) |